Speaker

Data

Titolo

Massimo d'Agostino,

MMBM

16.9

A New Light For Discovering New Drugs

Jessalyn Ubellacker,

Harvard Medical School

26.9

Inducing Lipid Oxidation In Lymph Nodes To Inhibit Cancer Metastasis

Gianluigi Veglia,

Minnesota University

9.10

Protein Kinase A in Motion: Mechanistic Insights into Function and Disease

Franca Esposito, MMBM

14.10

Translational Control Meets Metabolic Adaptation In Cancer

Max Gassman,

Zurich University

Martina Muckenthaler, Heidelberg University

22.10

Oxygen, Iron And Hb: Coping With Altitudes

Reprogramming The Immune Microenvironment With Iron

Francesca Pisani,

IBBC, Napoli

28.10

Spotlight On DDX11: Cellular Functions Of The Warsaw Breakage Syndrome DNA Helicase

Antonio Baldini, MMBM

4.11

Gene Haploinsufficiency, Development And Disease Mechanisms: Digeorge Syndrome As A Textbook Example

Gennaro Gambardella, Tigem, Napoli

11.11

From Lineage Tracing to Drug Prediction: Bioinformatics Approaches to study Breast Cancer Cell Heterogeneity

Chiara di Malta,

Tigem, Napoli

18.11

Uncovering Novel Mechanisms of Lysosomal Regulation: From Signaling Pathways to Exocytosis in Physiology and Disease

Giacomo Cavalli,

IGH, Montpellier

27.11

Polycomb proteins and 3D genome architecture in chromatin memory from flies to mouse

Danilo Fiore,

MMBM

4.12

Dissecting And Overcoming Drug Persistence In T-Cell Lymphoma

Silvia Piconese, Università La Sapienza

11.12

Ironic Regulatory T Cells In Cancer

Laura Marrone,

MMBM

18.12

Circulating Monocyte Signatures Predict Response to Cemiplimab in Cutaneous Squamous Cell Carcinoma

Domenico Grieco, MMBM

22.1

Contextual, spatiotemporally controlled, on and off Cdk1 states drive chromosome segregation

Claudia De Lorenzo, MMBM

27.1

Novel Immunomodulatory Mono-, Bi- And Tri-Specific Antibodies For Cancer Therapy

Diego Medina,

Tigem, Napoli

3.2

Illuminating A Cure: Bridging High-Content Imaging And In Vivo Models To Accelerate Therapies For Lysosomal Storage Diseases

Michela Grosso,

MMBM

10.2

GATA-1 from normal hematopoiesis to myeloid leukemia

Danilo Swann Matassa

MMBM

19.2

The two-faced role of Syndesmos: riboregulation of the DNA damage response

Lucio Pastore, MMBM

26.2

To be defined